Interleukin biochemistry and biology: summary and introduction
Gillis, S.
Federation Proceedings 42(9): 2635-2638
1983
ISSN/ISBN: 0014-9446 PMID: 6602067 Document Number: 209223
Document emailed within 1 workday
Related Documents
Arai, N.; Yokota, T.; de Vries, J.; Banchereau, J.; Takebe, Y.; Lee, F.; Arai, K. 1988: Molecular biology of T cell-derived lymphokines: structure and biology of interleukin 4 Developments in Biological Standardization 69: 57-63Goldstein, S.M.; Kaempfer, C.E.; Wintroub, B.U. 1989: Mast cell carboxypeptidase: biochemistry and biology Progress in Clinical and Biological Research 297: 145-154
Levchuk, I.M. 2003: The contribution of the Nobel laureates to biochemistry and molecular biology Ukrains'kyi Biokhimichnyi Zhurnal 75(5): 128-150
1995: American Society for Biochemistry and Molecular Biology. San Francisco, California, May 21-25, 1995. Abstracts Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 9(6): A1239-A1508
Kuzhman, M.I. 1973: Discussion of the article by G. V. Troitskiĭ and I. V. Okulov "The teaching of biochemistry and molecular biology in medical schools" Laboratornoe Delo 3: 183-184
Levy, Y.; Brouet, J.C. 1992: Biology of interleukin-6. Role in lymphoplasmacytic hemopathies Annales de Medecine Interne 143(8): 533-543
Young, N.S. 1990: Hematopoietic growth factors: a summary of their biology in tissue culture, animals, and clinical trials Progress in Clinical and Biological Research 337: 539-549
Pontén, J. 1998: Precancer biology: importance and possible prevention. Introduction Cancer surveys 32: 1-3
Rimm, D.L.; Sherman, M.E. 2000: The new Molecular Biology Section of Acta Cytologica. An introduction Acta Cytologica 44(5): 701-702
Zawilińska, B.; Kosz-Vnenchak, M. 2014: General introduction into the Ebola virus biology and disease Folia Medica Cracoviensia 54(3): 57-65
Joy, M. 1999: Introduction and summary of principal conclusions of the Second European Workshop in Aviation Cardiology European Heart Journal Supplements: Journal of the European Society of Cardiology 1 Suppl D: D1-12
Körner, I.J.; Hartwig, M.; Kopp, J. 1988: Human interleukin 2: molecular biology, physiology and clinical possibilities Zeitschrift für Arztliche Fortbildung 82(23): 1171-1174
García de Galdeano; Boyano, D.; Smith-Zubiaga, I.; Alvarez, A.; Cantón, I.; Cañavate, L. 1998: Involvement of interleukin-6 in the biology and metastatic activity of B16F10 melanoma cells European Cytokine Network 9(2): 187-192
Billadeau, D.; Jelinek, D.F.; Shah, N.; LeBien, T.W.; Van Ness, B. 1995: Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6 Cancer Research 55(16): 3640-3646
Schafer, H. 1973: The summary accounting sheet of the German Council for Forestry and its introduction into the accounting systems of the state forests of Baden-Wurttemberg Allgemeine Forstzeitschrift 28(19): 455-458
Durand, G. 1989: Glycan variants of human alpha 1-acid glycoprotein modulate the biology of macrophages. Evidence that a concanavalin A-unreactive variant is involved in the production of an interleukin 1 inhibitor Progress in Clinical and Biological Research 300: 247-265
Stokes, W.S.; Marafante, E. 1998: Introduction and summary of the 13th meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC): alternative testing methodologies Environmental Health Perspectives 106 Suppl. 2: 405-412
Kierszenbaum, F.; Lopez, H.M.; Sztein, M.B. 1996: Trypanosoma cruzi downregulates the production of interleukin-2, interferon-gamma, interleukin-4 and interleukin-5 by activated human lymphocytes Journal of Parasitology 82(4): 652-656
Alecu, M.; Geleriu, L.; Coman, G.; Gălăţescu, L. 1998: The interleukin-1, interleukin-2, interleukin-6 and tumour necrosis factor alpha serological levels in localised and systemic sclerosis Romanian Journal of Internal Medicine 36(3-4): 251-259
Bubeník, J.; Símová, J.; Zeuthen, J.; Diamant, M.; Jandlová, T.; Bubeníková, D. 1994: Gene therapy of plasmacytoma: comparison of the therapeutic efficacy of tumour cells transduced with the interleukin-2, interleukin-4, or interleukin-6 genes Folia Biologica 40(1-2): 29-36